6MWT - 6 minutter gangtest

Hjern​​eslag

Standardfeilen (SEM: Standard Error of Measurement):

• Kronisk hjerneslag: 12.4m (Eng et al., 2004)
• Kronisk hjerneslag (utendørs) 11.9m (Wevers et al., 2011)
• Hjerneslag (GPS) 18.1m (Wevers et al., 2011)
• Kvinne med kronisk hjerneslag: 18.6m (Flansbjer et al., 2005)
• Generelt: 11.9 – 23.2m (Machiavelli et al., 2020)

Minste målbare endring (MDC: Minimum Detectable Change):

• Subakutt hjerneslag : 61m (60.96m)?
• Kronisk hjerneslag: 43m (42.98m)
• Kronisk ryggskade: 46m (45.72m)
• Kronisk hjerneslag: 34.4m (Eng et al., 2004)
• Kronisk hjerneslag: 36.6m (Flasbjer et al., 2005)
• Subakott hjerneslag: 61.0m (Perera et al., 2006)

Minste klinisk relevante endring (MICD: Minimal Clinically Important Difference):

• Subakutt hjerneslag - liten endring: 20m (20.12m)
• Subakutt hjerneslag - betydelig endring: 50m (49.99)
• Kronisk hjerneslag: 34.4m
• Post-hjerneslag (2-6mnd), evne til gå 3 m med < maks assistanse, (Fulk 2018). (Fulk & He 2018):
• når initial ganghastighet <0,40 m / s = 44 m17
• når første ganghastighet ≥0,40 m / s = 71 m17

Reliabilitet​​​:

Test-retest reliabilitet: ICC - 0.98 (95%IC), (Eng et al., 2004, Flasberg et al., 2005, Fulk et al., 2oo8, Liu et al., 2008, Wever, et al., 2011 & Macchiavelli et al., 2020)

Interrate/intrarate reliability: ICC - 0.78 and 0.75 (Kosak & Smith 2005, Macchiavelli et al., 2020)

Kriterier/validitet (prediksjon​​/simutant):

• Kronisk hjerneslag (Flasbjer et al., 2005)

Validitet: TUG:r=0.89
10 meters gangtest med behagelig ganghastighet: r=0.84
10 meters gangtest med rask ganghestighet: r=0.94
Trappeklatring: r=0.82
Trappenedstigning: r=0.80

• Akutt hjerneslag (Kosak & Smith 2005)

Korrelasjon med
2 minutters gangtest: r=0.997
12 minutters gangtest: r=0.994

• Kronisk hjerneslag (Wevers et al., 2011)

Validitet ved første test utendørs: GPS og målehjul: r=0.98, p<0.000
Ved andre test utendørs: GPS og målehjul: r=0.99, p<0.000

Resp​​ons:

Standarizes Respons Means (SRM): 1.52 (Kosak & Smith 2005).

Lungesykdommer

Minste målbare endring (MDC:Minimum Detectable Change): 54 m (Redelmeier et al., 1997)

Minste klinisk relevante endring (MICD:Minimal Clinically Important Difference): 54 m Resekaba et al,. 2009)

N​​ormati​​ve data:

• Gjennomsnittlig gangavstand 380 m: range 160-660 m (Cassanova et al., 2007, & Szekely et al., 1997)
• Avstand < 200 m = prediktiv for sykehusinnleggelse eller dødelighet

Criterion validity​​ (predictive/​​concurrent):

• Manglende evne til å gå > 45: De beste prediktorene for uakseptabel postoperativ utfall og dødelighet (spesifisitet = 84%, sensitivitet = 82%) (szekely et al., 1997)

Tilstrekkelig korrelasjon m​ed lengde på s​​ykehusopphold:

• Pre-kirurgisk 6MWT: r=0.32
• Post-kirurgisk 6MWT: r=0.04

Res​​pons​​:

• Demonstrerer betydelig nedgang hos personer med alvorlig luftveisobstruksjon (Cassanove et al., 2007)
• Nedgang forverres med sykdommens alvorlighets

Parkinsons sykdom

Minste målbare endring (MDC: Mininum Detectable Change):

• 82 m (Steffen & Senney 2008, Steffen et al., 2008, Yahr 1-4, median 2)

Reli​ab​​ility:

• Test-retest: ICC = 0.95 - 0.96 (Steffen T, Seney 2008

Ryggmargskade

Standard Error of Measurement (SEM):

• 16.5 m (vanHedle et al., 2005, Lam et al., 2008).

Minste målbare endring (MDC: Minimum Detectable Change):

• 45m (Lam et al., 2008).

Minste klinisk relevante endring (MICD: Minimal Clinically Important Difference):

• Overall: 0.10 m/s
• Slow: 0.11 m/s (Forrest et al., 2014)

Reliabilitet:

• Inter/intra-rate: ICC – 0.99 (Scivoletto et al., 2011).
• Inter-rate: r = 0.97 (vanHedel et al., 2005).

Alzheimer's sykdom

Standard Error of Measurement (SEM):

• mild til moderat: 21.86 m
• moderat alvorlig til alvorlig: 19.57 m (Ries et al., 2009).

Minste målbare endring (MDC: Minimum Detectable Change):

• 33.47 m (Ries et al., 2009).

Reliabilitet:

• Test-retest: ICC = 0.98 – 0.99 (Ries et al., 2009).
• Inter-rate: ICC = 0.98 – 0.99 (Tappen et al., 1997)
• Intra-rate: ICC = 0.76 – 0.90 (Tappen et al., 1997)

Eldre voksne og eldreomsorg

Standard Error of Measurement (SEM):
Eldre med hjerneslag: (Perera et al., 2006).

• styrke treningstest: 21m
• intervensjonstest: 22m

Minste målbare endring (MDC: Minimum Detectable Change):

• 58 m (Perera et al., 2006).

Minste klinisk relevante endring (MICD: Minimal Clinically Important Difference):

• Eldre med hjerneslag: 50m (Perera et al., 2006)

Normativ endring:
Eldre hjemmeboende (Steffens et al., 2002)

Reliabilitet:

• Test-retest: r = 0.95 (Harada et al., 1999)
• Test-retest: r = 0.95 (Stepehn et al., 2002)

Responsiveness (responsiv?):

• Liten endring: 20 m
• Signifikant endring: 50 (Perera et al., 2002).

Multippel sklerose (MS): mean Expaned Disability Status Scale (EDSS) = 3.5)

• 88m or 20% change 10 (Learmonth et al., 2013)

Osteoartitt

Standard Error of Measurement (SEM):

• 26.29 m (Kennedy et el., 2005)

Minste målbare endring (MDC: Minimum Detectable Change):

• 61.34 m ((Kennedy et el., 2005)

Reliabilitet:

• Test-retest: ICC = 0.93 (Kennedy et el., 2005)

Hjerneskade

Reliabilitet

• Test-retest: ICC=0.94 (Mossberg et al., 2003)
• Test-retest: ICC=0.94 (VanLoo et al., 2004)

Huntingtons sykdom (HD: Huntington Disease)

Minste målbare endring (MDC: Minimum Detectable Change):

• pre-manifest: 39.2 m1 (Quinn et al., 2013).
• manifest: 86.6 m1
• tidlig-fase: 56.6 m1
• midt-stadie: 126.14 m1
• senstadie: 70.7 m1

Reliabilitet
Test-retest pålitelighet

• pre-manifest: ICC = 0.98 (Quinn et al., 2013).
• manifest: ICC = 0.94
• tidlig stadiet: ICC = 0.97
• midt-stadiet: ICC = 0.86
• sen-stadiet: ICC = 0.97

https://pubmed.ncbi.nlm.nih.gov/29901487/

https://neuropt.org/practice-resources/anpt-clinical-practice-guidelines/core-outcome-measures-cpg

FYSIOPRIM prosjektet ved UiO beskriver 6MWT i sammenheng med andre verktøy

ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111-117. 

Eng, J.J., Dawso. A.S., et al., (2004). Submaximal Exercise in Persons With Stroke: Test-Retest Reliability and Concurrent Validity With Maximal Oxygen. Arch Phys Med Rehabil Vol 85.
DOI: 10.1016/s0003-9993(03)00436-2. https://pubmed.ncbi.nlm.nih.gov/14970978/

Bohanen RW., Crouch R. (2017). Minimal clinically important difference for change in 6-minute walk test distance of adults with pathology: a systematic review. J Eval Clin Pract . 23(2):377-381. Doi: 10.1111/jep.12629. https://pubmed.ncbi.nlm.nih.gov/27592691/

Busk, H., Paetur Holm, P., Søren T Skou, ST., et al. (2023). Physiother Theory Pract. 39(5):1024-1032. doi: 10.1080/09593985.2022.2030830, https://pubmed.ncbi.nlm.nih.gov/35109744/

Casanova, C., Cote. C.G., et al. (2007). The 6-min walking distance: long-term follow up in patients with COPD. Eur Respir J: 29: 535–540.
DOI: 10.1183/09031936.00071506, https://pubmed.ncbi.nlm.nih.gov/17107991/

Cheng DK, Nelson M, Brooks D, Salbach NM (2020). Validation of stroke-specific protocols for the 10-meter walk test and 6-minute walk test conducted using 15-meter and 30-meter walkways. Top Stroke Rehabil; 27(4):251-261.  Doi: 10.1080/10749357.2019.1691815. https://pubmed.ncbi.nlm.nih.gov/15788341/
 
Flansbjer, U-B., Anna Maria Holmback. A.M., et al. (2005). Reliability of gait performance tests in men and women with hemiparesis after stroke. J Re. habil Med; 37: 75–82. DOI: 10.1080/16501970410017215, https://pubmed.ncbi.nlm.nih.gov/15788341/

Forrest, G.F., Karen Hutchinson K., et al. (2014). Are the 10 Meter and 6 Minute Walk Tests Redundant in Patients with Spinal Cord Injury?. PLoS one 9(5):e94108. 
https://doi.org/10.1371/journal.pone.0094108 https://pubmed.ncbi.nlm.nih.gov/24788068/

Fulk, G.D., & Echternach J.L., (2008). Test-retest reliability and minimal detectable change of gait speed in individuals undergoing rehabilitation after stroke. JNPT;32: 8–13. DOI: 10.1097/NPT0b013e31816593c0, https://pubmed.ncbi.nlm.nih.gov/18463550/

Fulk, G.D., & Y, He (2018). Minimal Clinically Important Difference of the 6-Minute Walk Test in People With Stroke. J Neurol Phys Ther. 2018 Oct;42(4):235-240
DOI: 10.1097/NPT.0000000000000236, https://pubmed.ncbi.nlm.nih.gov/30138230/ 

Guyatt, G.H., Sullivan, M.J., et al. (1985). The 6-minute walk: a new measure of exercise capacity in patients with chronic heart fail. Can Med Assoc J. 15;132(8):919-23.ure. PMCID: PMC1345899, https://pubmed.ncbi.nlm.nih.gov/3978515/.

Holland, A., Hill, C., Rasekaba, T., et al., (2010 ). Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 91(2):221-5. DOI:https://doi.org/10.1016/j.apmr.2009.10.017. https://pubmed.ncbi.nlm.nih.gov/20159125/

Harada, N.D., Chiu,V., et al. (1999). Mobility-related function in older adults: assessment with a 6-minute walk test. Arch Phys Med Rehabil.;80(7):837-41. DOI: 10.1016/s0003-9993(99)90236-8, https://pubmed.ncbi.nlm.nih.gov/10414771/.

Hansen, H., Beyer, N., Frølich, A., et al. (2018). Intra- and inter-rater reproducibility of the 6-minute walk test and the 30-second sit-to-stand test in patients with severe and very severe COPD. Int J Chron Obstruct Pulmon Dis. 13: 3447–3457. doi: 10.2147/COPD.S174248, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203115/ 

Kennedy, D.M., Stratford, P.W., et al. (2005). Assessing stability and change of four performance measures: a longitudinal study evaluating outcome following total hip and knee arthroplasty. BMC Musculoskelet Disord. 28;6:3. DOI: 10.1186/1471-2474-6-3, https://pubmed.ncbi.nlm.nih.gov/15679884/.

Marc Kosak, M., & Teresa Smith, T., (2005). Comparison of the 2-, 6-, and 12-minute walk tests in patients with stroke. J Rehabil Res Dev.;42(1):103-7. 
DOI: 10.1682/jrrd.2003.11.0171. https://pubmed.ncbi.nlm.nih.gov/15742254/

Kennedy, D.M., Stratford,P.W., et al. (2005). Assessing stability and change of four performance measures: a longitudinal study evaluating outcome following total hip and knee arthroplasty. BMC Musculoskelet Disord. 28;6:3. DOI: 10.1186/1471-2474-6-3 https://pubmed.ncbi.nlm.nih.gov/15679884/

Khan MS, Anker SD, Friede T et al., 2022. Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency. J Cardiac Failure; 29 (5). DOI: 10.1016/j.cardfail.2022.10.423

Lam, T., Noonan, V.K., et al. (2008). A systematic review of functional ambulation outcome measures in spinal cord injury. Spinal Cord.;46(4):24 6-54. DOI: 10.1038/sj.sc.3102134, https://pubmed.ncbi.nlm.nih.gov/17923844/

Learmonth, Y.C., Dlugonski, D.D., et al. (2013). The reliability, precision and clinically meaningful change of walking assess- ments in multiple sclerosis. Mult Scler. 19(13):1784-91. DOI: 10.1177/1352458513483890, https://pubmed.ncbi.nlm.nih.gov/23587605/.

Macchiavelli, A., Giffone, A., et al. (2020). Reliability of the six-minute walk test in individuals with stroke: systematic review and meta-analysis. Neurol Sci.. DOI: 10.1007/s10072-020-04829-0, https://pubmed.ncbi.nlm.nih.gov/33064231/

Moseley, A.M, Lanzarone, S., et al. (2004). Ecological validity of walking speed assessment after traumatic brain injury: a pilot study. J Head Trauma Rehabil.;19(4):341-8.
DOI: 10.1097/, 0001199-200407000-00008, https://pubmed.ncbi.nlm.nih.gov/15263861/ 

Mossberg, K.A. (2003). Reliability of a timed walk test in persons with acquired brain i. njury. Am J Phys Med Rehabil.;82(5):385-90.
DOI: 10.1097/01.PHM.0000052589.96202.BE. https://pubmed.ncbi.nlm.nih.gov/12704280/

Puhan, M., Mador, M.,  Held. U., et al., (2008). Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J. ;32(3):637-43.DOI: 10.1183/09031936.00140507. https://pubmed.ncbi.nlm.nih.gov/18550610/

Perera, S., Mody, S.H., et al. (2006). Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc.;54(5):743-9. 
DOI: 10.1111/j.1532-5415.2006.00701.x. https://pubmed.ncbi.nlm.nih.gov/16696738/ 

Rasekaba, T., Lee, A.L., et a., (2009). The six-minute walk test: a useful metric for the cardiopulmonary patient. Intern Med J. 2009 Aug;39(8):495-501.
DOI: 10.1111/j.1445-5994.2008.01880.x, https://pubmed.ncbi.nlm.nih.gov/19732197/ 
 
Redelmeier, D.A., Bayoumi, A.M., et al. (1997). Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med. 155(4):1278-82.
DOI: 10.1164/ajrccm.155.4.9105067. https://pubmed.ncbi.nlm.nih.gov/9105067/

Ries, J.D., Echternach,J.L., et al. (2009). Test-retest reliability and minimal detectable change scores for the timed "up & go" test, the six-minute walk test, and gait speed in people with Alzheimer disease. Phys Ther. 89(6):569-79. DOI: 10.2522/ptj.20080258. https://pubmed.ncbi.nlm.nih.gov/19389792/ 

Sandberg, A., Cider, Å, Jivegård, L., et al. (2019). Test-retest reliability, agreement, and minimal detectable change in the 6-minute walk test in patients with intermittent claudication. https://www.jvascsurg.org/article/S0741-5214(19)30531-2/fulltext. DOI:https://doi.org/10.1016/j.jvs.2019.02.056.  

Scivoletto, G., Tamburella,F., et al. (2011). Validity and reliability of the 10-m walk test and the 6-min walk test in spinal cord injury patients. Spinal Cord. 49(6):736-40. DOI: 10.1038/sc.2010.180. https://pubmed.ncbi.nlm.nih.gov/21221120/

Sheraz S., Ferraro F.V., Razaq A., et al., (2022). Clinically Meaningful Change in 6 Minute Walking Test and the Incremental Shuttle Walking Test Following Coronary Artery Bypass Graft Surgery. Int. J. Environ. Res. Public Health:  19(21), 14270.
https://doi.org/10.3390/ijerph192114270.

Steffen, T.M, Seney, M. (2008). Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-item short-form health survey, and the unified Parkinson disease rating scale in people with parkinsonism. Phys Ther. 88(6):733-46.
DOI: 10.2522/ptj.20070214, https://pubmed.ncbi.nlm.nih.gov/18356292/ 

Steffen T.M., Hacker, T.A., et al. (2002). Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds. Phys Ther. 82(2):128-37
DOI: 10.1093/ptj/82.2.128. https://pubmed.ncbi.nlm.nih.gov/11856064/

Szekely, L.A., Oelberg, D.A., et al. (1997). Preoperative predictors of operative morbidity and mortality in COPD patients undergoing bilateral lung volume reduction surgery. Chest. 1997 Mar;111(3):550-8.
DOI: 10.1378/chest.111.3.550. https://pubmed.ncbi.nlm.nih.gov/9118686/ 

Tappen, R.M., Roach, K.E., et al. (1997). Reliability of physical performance measures in nursing home residents with Alzheimer's. J Gerontol A Biol Sci Med Sci. 52(1):M52-5. DOI: 10.1093/gerona/52a.1.m52, https://pubmed.ncbi.nlm.nih.gov/9008669/ 

van Hedel, H.J., M Wirz, M., et al. (2006). Improving walking assessment in subjects with an incomplete spinal cord injury: responsiveness. Spinal Cord. 44(6):352-6.
DOI: 10.1038/sj.sc.3101853, https://pubmed.ncbi.nlm.nih.gov/16304565/

van Hedel, H.J., Wirz, M., et al. (2005). Assessing walking ability in subjects with spinal cord injury: validity and reliability of 3 walking tests Arch Phys Med Rehabil. 86(2):190-6..
DOI: 10.1016/j.apmr.2004.02.010. https://pubmed.ncbi.nlm.nih.gov/15706542/ 

van Loo, M.A., Moseley,A.M., et al. (2004). Test-re-test reliability of walking speed, step length and step width measurement after traumatic brain injury: a pilot study. Brain Inj. 2004 Oct;18(10):1041-8. DOI: 10.1080/02699050410001672314. https://pubmed.ncbi.nlm.nih.gov/15370902/ 

Wevers,L .E.G., Gert Kwakkel, G., et al.(2011). Is outdoor use of the six-minute walk test with a global positioning system in stroke patients' own neighbourhoods reproducible and valid?
Affiliations expandJ Rehabil Med. 43(11):1027-31.
DOI: 10.2340/16501977-0881. https://pubmed.ncbi.nlm.nih.gov/22031349/